Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-18-049581)

Filing Details

Accession Number:: 0001144204-18-049581
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-09-14 21:04:41
Reporting Period:: 2018-09-12

Accepted Time:: 2018-09-14 21:04:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1069899	Phibro Animal Health Corp	PAHC	Pharmaceutical Preparations (2834)	131840497

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1601607	Bfi Co., Llc	300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2018-09-12	30,000	$0.00	60,000	No	4	C	Direct
Class A Common Stock	Disposition	2018-09-12	520	$45.04	59,480	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Class B Common Stock	Disposition	2018-09-12	30,000	$0.00	30,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,166,034			No	4	C	Direct

Footnotes

Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.10, inclusive.